Composition:
Zilsart 40 : Each film-coated tablet contains Azilsartan Kamedoxomil INN equivalent to Azilsartan Medoxomil 40 mg.
Indications
Zilsart (Azilsartan Medoxomil) is indicated for the treatment of hypertension. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It may be used alone or in combination with other antihypertensive agents.
Dosage and Administration
The recommended starting dose of Zilsart is 40 mg once daily. The dose may be increased to a maximum of 80 mg once daily for patients whose blood pressure is not adequately controlled at the lower dose. Zilsart may be administrated with other antihypertensive agents for further blood pressure reduction if needed. Azilsartan may be taken with or without food.
No initial dose adjustment is required with mild-to-severe renal impairment or end stage renal disease. Patients with moderate to severe renal impairment are more likely to report abnormally high serum creatinine values.
Dose adjustment is not necessary with mild-to-moderate hepatic impairment. Azilsartan has not been studied in patients with severe hepatic impairment and therefore its use is not recommended in this patient group.
No adjustment with Azilsartan is necessary in elderly patients
OR AS DIRECTED BY PHYSICIAN.
